NCT02943057View on ClinicalTrials.gov

Topical 2% Ganciclovir Eye Drop for CMV Anterior Uveitis / Endotheliitis

PHASE4CompletedINTERVENTIONAL
Enrollment

25

Participants

Timeline

Start Date

October 31, 2016

Primary Completion Date

January 31, 2024

Study Completion Date

November 30, 2024

Conditions
Cytomegalovirus Infections
Interventions
DRUG

2% guttae ganciclovir

2% guttae ganciclovir 5 times a day for 6 weeks

Trial Locations (1)

Unknown

Singapore National Eye Centre, Singapore

All Listed Sponsors
lead

Singapore National Eye Centre

OTHER_GOV

NCT02943057 - Topical 2% Ganciclovir Eye Drop for CMV Anterior Uveitis / Endotheliitis | Biotech Hunter | Biotech Hunter